Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. Right ...

Lilly's SVP of Talent said diverse backgrounds, skills and perspectives "fuel" innovation and "strengthen the understanding ...

Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies ...

Gin Blossoms will join Power to the Patients (PTTP) in Washington, D.C., for a special performance in support of true price transparency in healthcare. The PTTP Congressional Baseball Game Pre-Party ...

A significant trading signal occurred for Eli Lilly stock, as it demonstrated a power inflow at $734.98, after which LLY rose ...

Analysis by specialist staffing firm Xpheno Research shows that in the case of 145 GCCs set up in the last 30 months, 40 per ...

FOR Hope Lancaster Colquhoun, her perfect smile had always been a source of pride – so it was a moment of pure horror when ...

The widespread hunt for candidates who are equally versed in tech and healthcare is making AI recruiting a challenge.

The Chicago native will screen the cult classic ‘Bound’ this week as part of Sapphopalooza. “Our films are remaining relevant ...

The stock's rise snapped a five-day losing streak.

Ignite’s home matches this year, partly through support from Lilly, the presenting sponsor of the team’s inaugural season.

Eli Lilly has received approval in Australia to market its Alzheimer's treatment Kisunla. The pharmaceutical company said Wednesday the Australian Therapeutic Goods Administration granted marketing ...